IEC On-Demand Webcasts

In effort to bring valuable information and education to a wider audience, the IEC continues to develop webcasts of the symposia taking place throughout the year. In each of these webcasts, leading experts in atopic dermatitis provide new insights and promote management through research, education, and patient/family care.

Please enjoy these complimentary webcasts. The IEC will announce new webcasts as they become available. 

Novel Systemic Treatments for Atopic Dermatitis and Clinical Trial Design  

  • Optimizing Clinical Trial Design for AD drug development 
  • Novel Systemic Treatments in Pediatrics and Placebo Responses in Systemic Trials 
  • Monoclonal antibodies targeting Th2 receptors and cytokines (e.g. IL4R, IL-13 and IL-31)
  • Monoclonal antibodies targeting epithelial-derived protein (e.g. IL-17C, IL-33 and TSLP) 
  • Monoclonal antibodies with other targets (e.g. OX40, IL-22 and IL-23) and biomarkers of disease response 
  • Systemic JAK inhibitors 
  • Topical JAK inhibitors
See modules
 Evaluate On-Demand Webcast

 

New Treatments for Atopic Dermatitis in Infants and Children 

  • Overview of Pediatric AD
  • Mechanisms for Prevention of AD
  • Topical Therapies
  • Systemic Therapies
See modules

 

Management of AD Patients on Systemic Treatments during COVID-19

  • COVID-19 and Pediatric AD Patients 
  • COVID-19 and Adult AD Patients 
  • COVID-19 New York Patients Atopic Dermatitis Topical Study Design 
  • SECURE-AD Registry
See modules

 

New Topical Developments and Preventive Mechanisms

  • Atopic Dermatitis Topical Study Design
  • Mechanisms for Prevention of AD
  • PDE-4 Inhibitors
  • Topical Therapies: Tapinarof and Beyond
See modules

 

Atopic Dermatitis Comorbidities

  • Atopic Comorbidities (e.g., asthma, hay fever, food allergy)
  • Cardiovascular Comorbidities (e.g., diabetes and CVD)
  • Autoimmune Comorbidities (e.g., vitiligo, urticaria, AA, RA)
  • Cutaneous Comorbidities (e.g., contact allergy, irritant contact dermatitis, occupational hand eczema, infections, skin cancer)
  • Psychiatric Comorbidities (e.g., anxiety, depression, sleep disorders, ADHD)
  • Economics and Healthcare in Atopic Dermatitis
See modules